Cipher Pharmaceuticals Inc. (T.DND) hit a new 52-week high of $1.75 Monday.
Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica™, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne. Absorica is expected to be launched in the U.S. in Q4 2012. Cipher Pharmaceuticals Inc.
Northland Power Inc. (T.NPI) hit a new 52-week high of $18.24 Monday. No news announcements today
Medical Facilities Corporation (T.DR) hit a new 52-week high of $13.71 Monday. No news announcements today
Black Diamond Group Limited (T.BDI) hit a new 52-week high of $22.83 Monday. No news announcements today
Mainstreet Equity Corp. (T.MEQ) hit a new 52-week high of $26.70 Monday. No news announcements today
The Brick Ltd. (T.BRK) hit a new 52-week high of $4.00 Monday. No news announcements today
Alaris Royalty Corp. (T.AD) hit a new 52-week high of $20.72 Monday. No news announcements today
Related Stories
